Therapy

Disclaimer:

The application is under development! This application is designed as a tool for doctors to quickly and easily select the optimal drug therapy for the treatment of glaucoma, primarily by not offering drugs that would be contraindicated with regard to the indicated conditions or diseases, and then by providing a clear overview that allows for comparison of non-contradicted drugs. The final decision and responsibility for prescribing a drug lies with the doctor. Before each prescription of a drug, it is recommended to read the drug package insert, which contains information on the indications, contraindications, precautions and side effects of the drug in question. The authors of the application disclaim any liability that may arise from prescribing a drug based solely on its use.

Please indicate what applies to the patient:

Drugs:

Mark	Description	Percentage of blood pressure lowering effect
	Prostaglandin analogues and Prostamide	25-35%
	Beta blockers	20-25%
	Carbonic anhydrase inhibitors	20% (systemic 30-40%)
	Alpha agonists	18-25%
	Parasympathomimetics	20-25%
	Osmotic	15-30%
	Preservative	-
sdc	single-dose container	-

Name (short) Sort:ascending descending	Active matter	Strength	Preservative Filter:With Preservative Without Preservative	Manufacturer/AH Sort:ascending descending
PF Zioptan	Tafluprost 0.0015%	0.015 mg/mL		THEA PHARMA
Lumigan 0.01%	Bimatoprost	0.1 mg/mL	benzalkonium chloride (0.2 mg/mL)	Allergan
Lumigan 0.03%	Bimatoprost	0.3 mg/mL	benzalkonium chloride (0.05 mg/mL)	Allergan
Xalatan	Latanoprost	50 μg/mL	BAK (0.20 mg/ml)	Pfizer
Vyzulta	Latanoprostene	0.24 mg/mL	benzalkonium chloride 0.2 mg/mL	Bausch + Lomb
Travatan	Travoprost	40 μcg/ml	POLYQUAD (10 μg/ml)	Alcon
Istalol	Timolol	5 mg/mL		ISTA Pharmaceuticals, Inc.
Betagan	Levobunolol hydrochloride	0.50%	benzalkonium chloride 0.004%	Allergan
Timoptic 0.25%	Timolol	2.5 mg/mL	Benzalkonium chloride 0.01%	Merck & Co., Inc.
Timoptic 0.5%	Timolol	5 mg/mL	Benzalkonium chloride 0.01%	Merck & Co., Inc.
Alphagan	Brimonidine tartrate	2 mg/mL	benzalkonium chloride	Allergan
Alphagan P 0.1%	Brimonidine tartrate	1.0 mg/mL	PURITE® 0.005% (0.05 mg/mL)	Allergan
Alphagan P 0.15%	Brimonidine tartrate	1.5 mg/mL	PURITE® 0.005% (0.05 mg/mL)	Allergan
Azopt	Brinzolamide	10 mg/mL	Benzalkonium chloride 0.01%	Alcon, Inc.
Trusopt	Dorzolamide hydrochloride	20 mg/mL	Benzalkonium chloride 0.0075%	Merck & Co., Inc.
Combigan	Brimonidine tartrate, Timolol	2 mg/mL brimonidine tartrate and 5 mg/mL timolol	Benzalkonium chloride 0.005% (0.05 mg/ml)	Abbvie
Cosopt	Dorzolamide, Hydrochloride-timolol	20 mg/mL dorzolamide and 5 mg/mL timolol	Benzalkonium chloride 0.0075%	MERCK & CO., Inc.
Simbrinza	Brinzolamide, Brimonidine	(10 mg/mL) brinzolamide and 0.2% (2 mg/mL) brimonidine	benzalkonium chloride	Alcon, Inc.

We created a tool for doctors to choose the optimal drug therapy for the treatment of glaucoma faster and easier, primarily by not offering drugs that would be contraindicated with regard to the indicated conditions or diseases, and then by providing an overview that enables the comparison of non-contraindication drugs

Since every country has different set of rules and list of drugs, we created separate websites/portals for each country, with various therapy tools, diagnostic tools and glaucoma information in general.

We are working on adding more countries, if you can help us bring our tools to other countries please contact us at info@dares.co.

Disclaimer:

Internet Explorer

Please indicate what applies to the patient:

Drugs: